BELLUSCURA PLC Logo

BELLUSCURA PLC

Develops portable oxygen concentrators for patients needing supplemental oxygen.

BELL | IL

Overview

Corporate Details

ISIN(s):
GB00BD3B8Z11 (+2 more)
LEI:
213800BRJQZE56XBPW94
Country:
United Kingdom
Address:
15 FETTER LANE, EC4A 1BW LONDON
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Belluscura PLC is a medical device company focused on developing and manufacturing advanced oxygen enrichment technologies to improve the quality of life for patients requiring supplemental oxygen. The company's principal products are its lightweight and compact portable oxygen concentrators (POCs), including the FDA-cleared X-PLOR® and the DISCOV-R™. These devices are engineered with proprietary technologies, such as the patented ModulAir™ system and an 'Airgonomical™' design, to provide greater mobility and independence than traditional oxygen tanks. Belluscura aims to help patients with lung diseases lead healthier and more active lives through its innovative and approachable oxygen therapy solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-22 08:00
Capital/Financing Update
Directorate Change
English 17.6 KB
2025-09-12 17:57
Board/Management Information
Board Appointment
English 21.1 KB
2025-08-11 08:00
Capital/Financing Update
Update re Strategic Review and Proposed Fundraise
English 14.2 KB
2025-06-30 08:00
Capital/Financing Update
Strategic Review Update and Proposed Fundraising
English 19.3 KB
2025-06-19 12:07
Major Shareholding Notification
Holding(s) in Company - Replacement
English 52.5 KB
2025-06-18 18:01
Major Shareholding Notification
Holding(s) in Company
English 52.0 KB
2025-03-27 16:15
Major Shareholding Notification
Holding(s) in Company
English 52.1 KB
2025-03-10 18:49
Major Shareholding Notification
Holding(s) in Company
English 52.4 KB
2025-03-06 17:21
Major Shareholding Notification
Holding(s) in Company
English 22.8 KB
2025-03-06 14:08
Major Shareholding Notification
Holding(s) in Company
English 52.4 KB
2025-03-05 15:21
Major Shareholding Notification
Holding(s) in Company
English 21.7 KB
2025-03-04 16:50
Major Shareholding Notification
Holding(s) in Company
English 22.8 KB
2025-02-28 16:44
Post-Annual General Meeting Information
Replacement: Result of General Meeting
English 66.9 KB
2025-02-28 14:32
Post-Annual General Meeting Information
Result of General Meeting
English 65.9 KB
2025-02-13 08:30
Major Shareholding Notification
Holding(s) in Company
English 52.3 KB

Automate Your Workflow. Get a real-time feed of all BELLUSCURA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BELLUSCURA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ProstaLund AB Logo
Develops minimally invasive heat treatments and devices for BPH for global healthcare providers.
Sweden PLUN
Prostatype Genomics AB Logo
Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.
Sweden PROGEN
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.
South Korea 317690
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea 214260
Redsense Medical AB Logo
Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.
Sweden REDS
Revenio Group Oyj Logo
Develops ophthalmic devices and software for early detection of significant eye diseases.
Finland REG1V
ROKIT HEALTHCARE Inc. Logo
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea 376900
RootLoc Co., Ltd. Logo
Develops and sells orthopedic solutions like artificial joints and spinal implants globally.
South Korea 253610

Talk to a Data Expert

Have a question? We'll get back to you promptly.